Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Aguggia

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Parkinsonism & Related Disorders|February 3, 2020
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia?Giovanni Defazio, Giovanni Fabbrini, Roberto Erro, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 20, 2020
Correction to: Demographic and clinical determinants of neck pain in idiopathic cervical dystoniaMichele Tinazzi, Roberto Erro, Marcello Mario Mascia, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 28, 2020
Demographic and clinical determinants of neck pain in idiopathic cervical dystoniaMichele Tinazzi, Roberto Erro, Marcello Mario Mascia, et al.
Frontiers in Neurology|October 5, 2020
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia RegistryFrancesca Di Biasio, Roberta Marchese, Giovanni Abbruzzese, et al.
The Journal of Headache and Pain|October 2, 2025
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE)Piero Barbanti, Giulia Fiorentini, Cecilia Camarda, et al.
Neurology|January 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA CohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Neurology|May 27, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA CohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Cephalalgia : an International Journal of Headache|June 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Parkinsonism & Related Disorders|February 3, 2020
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia?Giovanni Defazio, Giovanni Fabbrini, Roberto Erro, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 20, 2020
Correction to: Demographic and clinical determinants of neck pain in idiopathic cervical dystoniaMichele Tinazzi, Roberto Erro, Marcello Mario Mascia, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 28, 2020
Demographic and clinical determinants of neck pain in idiopathic cervical dystoniaMichele Tinazzi, Roberto Erro, Marcello Mario Mascia, et al.
Frontiers in Neurology|October 5, 2020
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia RegistryFrancesca Di Biasio, Roberta Marchese, Giovanni Abbruzzese, et al.
The Journal of Headache and Pain|October 2, 2025
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE)Piero Barbanti, Giulia Fiorentini, Cecilia Camarda, et al.
Neurology|January 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA CohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Neurology|May 27, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA CohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Cephalalgia : an International Journal of Headache|June 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Pageof 4